Bicycle therapeutics to participate in the oppenheimer 32nd annual healthcare conference

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that management will participate in a fireside chat at the oppenheimer 32nd annual healthcare conference on tuesday, march 15, 2022 at 8:00 a.m. et. the conference will be held in a virtual meeting format. a live webcast of the fireside chat will be
BCYC Ratings Summary
BCYC Quant Ranking